Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

269105 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

36
37
38
39
40
... 17941

Send results to Selected: 0 Clear selection

Chang X, Tse AM, Fayzullina M, Albanese A, Kim M, Wang CF, Zheng Z, Joshi RV, Williams CK, Magaki SD, Vinters HV, Jones JO, Haworth IS, Seidler PM. Monoaminergic neurotransmitters are bimodal effectors of tau aggregation. Sci Adv. 2025 Jan 31;11(5):eadr8055. Epub 2025 Jan 31 PubMed.

Benítez Agudelo JC, Navarro Lechuga E, Flórez Lozano KC, Barceló Martínez E, de Oro Aguado CM. [Neuropsychological markers and factors associated with amnesic mild cognitive impairment]. Rev Esp Geriatr Gerontol. 2025 Jan 31;60(2):101620. Epub 2025 Jan 31 PubMed.

Liu D, Ma X, Li X, Li K, Bu Q, Zhou L. Correlation study between the microstructural abnormalities of medial prefrontal cortex and white matter hyperintensities with mild cognitive impairment patients: A diffusion kurtosis imaging study. Psychiatry Res Neuroimaging. 2025 Jan 31;348:111958. Epub 2025 Jan 31 PubMed.

Zhang C, Liu X, Wang J, Zhou G, Geng B, Hu M, Tang Q. Investigating the causal relationships between lipid traits and dementia with lewy bodies: A mendelian randomization study. Parkinsonism Relat Disord. 2025 Jan 31;:107312. Epub 2025 Jan 31 PubMed.

Alarcón-Espósito J, Nagiri RK, Gan L, Sinha SC. Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease. Neurotherapeutics. 2025 Jan 31;:e00536. Epub 2025 Jan 31 PubMed.

Pilotto A, Galli A, Sala A, Caminiti SP, Presotto L, Liguori C, Mercuri NB, Premi E, Garibotto V, Frisoni G, Chiaravalloti A, Schillaci O, D'Amelio M, Paghera B, Lucchini S, Bertagna F, Perani D, Padovani A. Dopaminergic deficits along the spectrum of Alzheimer's disease. Mol Psychiatry. 2025 Jan 31; Epub 2025 Jan 31 PubMed.

Jiménez-Ramírez IA, Castaño E. Non-coding RNAs in the pathogenesis of Alzheimer's disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation. Mol Biol Rep. 2025 Jan 31;52(1):183. PubMed.

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, Calon F, Camicioli R, Campbell B, Collins DL, Dadar M, DeMarco ML, Ducharme S, Duchesne S, Einstein G, Fisk JD, Gawryluk JR, Grossman L, Ismail Z, Itzhak I, Joshi M, Harrison A, Kroger E, Kumar S, Laforce R, Lanctot KL, Lau M, Lee L, Masellis M, Massoud F, Mitchell SB, Montero-Odasso M, Myers Barnett K, Nygaard HB, Pasternak SH, Peters J, Rajah MN, Robillard JM, Rockwood K, Rosa-Neto P, Seitz DP, Soucy JP, Trenaman SC, Wellington CL, Zadem A, Chertkow H, Canadian Consortium on Neurodegeneration in Aging Investigators. Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research. J Prev Alzheimers Dis. 2025 Jan 31;:100068. Epub 2025 Jan 31 PubMed.

Hachamnia AH, Mehri A, Jamaati M. Integrating neuroscience and artificial intelligence: EEG analysis using ensemble learning for diagnosis Alzheimer's disease and frontotemporal dementia. J Neurosci Methods. 2025 Jan 31;416:110377. Epub 2025 Jan 31 PubMed.

Botta D, Hutuca I, Sveikata L, Assal F, Lövblad KO, Kurz FT. Emerging non-invasive MRI techniques for glymphatic system assessment in neurodegenerative disease. J Neuroradiol. 2025 Jan 31;:101322. Epub 2025 Jan 31 PubMed.

Benatar M, Heiman-Patterson TD, Cooper-Knock J, Brickman D, Casaletto KB, Goutman SA, Vinceti M, Dratch L, Arias JJ, Swidler J, Turner MR, Shefner J, Westeneng HJ, van den Berg LH, Al-Chalabi A, Attendees of the Workshop on Guidance for Clinical Care of People Living with a Pathogenic Variant At-Risk for ALS and FTD. Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. J Neurol Neurosurg Psychiatry. 2025 Jan 31; Epub 2025 Jan 31 PubMed.

Dino FR, Pressman PS, Cohen KB, Dubljevic V, Jarrold W, Foltz PW, DeCamp M, Mahoor MH, Hunter LE. Ethics in digital phenotyping: considerations regarding Alzheimer's disease, speech and artificial intelligence. J Med Ethics. 2025 Jan 31; Epub 2025 Jan 31 PubMed.

Zhao W, Yang R, Meng X, Xu SQ, Li MM, Hao ZC, Wang SY, Jiang YK, Naseem A, Chen QS, Zhang LL, Kuang HX, Yang BY, Liu Y. Panax quinquefolium saponins protects neuronal activity by promoting mitophagy in both in vitro and in vivo models of Alzheimer's disease. J Ethnopharmacol. 2025 Jan 31;340:119250. Epub 2024 Dec 14 PubMed.

Zhang Y, Liu S, Cao D, Zhao M, Lu H, Wang P. Rg1 improves Alzheimer's disease by regulating mitochondrial dynamics mediated by the AMPK/Drp1 signaling pathway. J Ethnopharmacol. 2025 Jan 31;340:119285. Epub 2024 Dec 27 PubMed.

Oguro A, Uemura T, Machida K, Kitajiri K, Tajima A, Furuchi T, Kawai G, Imataka H. Polyamines enhance repeat-associated non-AUG translation from CCUG repeats by stabilizing the tertiary structure of RNA. J Biol Chem. 2025 Jan 31;:108251. Epub 2025 Jan 31 PubMed.

Go to another page:

36
37
38
39
40
... 17941

Current Filters

No filters selected

Filter By

Papers of the Week

Current Week (369)
17-23 Jan 2025 (296)
10-16 Jan 2025 (316)
3-9 Jan 2025 (386)

Type ?

Milestone (286)
Alzforum Recommends (3829)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us